Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 72

1.

Separation of breast cancer and organ microenvironment transcriptomes in metastases.

Alzubi MA, Turner TH, Olex AL, Sohal SS, Tobin NP, Recio SG, Bergh J, Hatschek T, Parker JS, Sartorius CA, Perou CM, Dozmorov MG, Harrell JC.

Breast Cancer Res. 2019 Mar 6;21(1):36. doi: 10.1186/s13058-019-1123-2.

2.

Potential Molecular Targets of Statins in the Prevention of Hepatocarcinogenesis.

Ridruejo E, Romero-Caími G, Obregón MJ, Kleiman de Pisarev D, Alvarez L.

Ann Hepatol. 2018 May-June;17(3):490-500. doi: 10.5604/01.3001.0011.7394. Epub 2018 Apr 9.

3.

Monoclonal Antibodies Directed against Cadherin RGD Exhibit Therapeutic Activity against Melanoma and Colorectal Cancer Metastasis.

Bartolomé RA, Aizpurua C, Jaén M, Torres S, Calviño E, Imbaud JI, Casal JI.

Clin Cancer Res. 2018 Jan 15;24(2):433-444. doi: 10.1158/1078-0432.CCR-17-1444. Epub 2017 Sep 15.

4.

Parthenolide attenuates 7,12-dimethylbenz[a]anthracene induced hamster buccal pouch carcinogenesis.

Baskaran N, Selvam GS, Yuvaraj S, Abhishek A.

Mol Cell Biochem. 2018 Mar;440(1-2):11-22. doi: 10.1007/s11010-017-3151-5. Epub 2017 Aug 12.

PMID:
28801714
5.

Quercetin Reverses Rat Liver Preneoplastic Lesions Induced by Chemical Carcinogenesis.

Carrasco-Torres G, Monroy-Ramírez HC, Martínez-Guerra AA, Baltiérrez-Hoyos R, Romero-Tlalolini MLÁ, Villa-Treviño S, Sánchez-Chino X, Vásquez-Garzón VR.

Oxid Med Cell Longev. 2017;2017:4674918. doi: 10.1155/2017/4674918. Epub 2017 Jun 27.

6.

Dual Inhibition of EGFR and c-Src by Cetuximab and Dasatinib Combined with FOLFOX Chemotherapy in Patients with Metastatic Colorectal Cancer.

Parseghian CM, Parikh NU, Wu JY, Jiang ZQ, Henderson L, Tian F, Pastor B, Ychou M, Raghav K, Dasari A, Fogelman DR, Katsiampoura AD, Menter DG, Wolff RA, Eng C, Overman MJ, Thierry AR, Gallick GE, Kopetz S.

Clin Cancer Res. 2017 Aug 1;23(15):4146-4154. doi: 10.1158/1078-0432.CCR-16-3138. Epub 2017 Mar 9.

7.

Polymeric immunoglobulin receptor promotes tumor growth in hepatocellular carcinoma.

Yue X, Ai J, Xu Y, Chen Y, Huang M, Yang X, Hu B, Zhang H, He C, Yang X, Tang W, Peng X, Dong L, Wang H, Fan J, Ding J, Geng M.

Hepatology. 2017 Jun;65(6):1948-1962. doi: 10.1002/hep.29036. Epub 2017 Apr 28.

PMID:
28073159
8.

Role of Akt2 in regulation of metastasis suppressor 1 expression and colorectal cancer metastasis.

Agarwal E, Robb CM, Smith LM, Brattain MG, Wang J, Black JD, Chowdhury S.

Oncogene. 2017 Jun 1;36(22):3104-3118. doi: 10.1038/onc.2016.460. Epub 2017 Jan 9.

9.

Inhibition of β-catenin signaling by phenobarbital in hepatoma cells in vitro.

Groll N, Petrikat T, Vetter S, Wenz C, Dengjel J, Gretzmeier C, Weiss F, Poetz O, Joos TO, Schwarz M, Braeuning A.

Toxicology. 2016 Aug 31;370:94-105. doi: 10.1016/j.tox.2016.09.018. Epub 2016 Sep 30.

PMID:
27693619
10.

Proteinase-activated receptor 2 (PAR2) in hepatic stellate cells - evidence for a role in hepatocellular carcinoma growth in vivo.

Mußbach F, Ungefroren H, Günther B, Katenkamp K, Henklein P, Westermann M, Settmacher U, Lenk L, Sebens S, Müller JP, Böhmer FD, Kaufmann R.

Mol Cancer. 2016 Jul 29;15(1):54. doi: 10.1186/s12943-016-0538-y.

11.

Dynamic Change of Polarity in Primary Cultured Spheroids of Human Colorectal Adenocarcinoma and Its Role in Metastasis.

Okuyama H, Kondo J, Sato Y, Endo H, Nakajima A, Piulats JM, Tomita Y, Fujiwara T, Itoh Y, Mizoguchi A, Ohue M, Inoue M.

Am J Pathol. 2016 Apr;186(4):899-911. doi: 10.1016/j.ajpath.2015.12.011. Epub 2016 Feb 12.

PMID:
26878211
12.

Intravital FRAP Imaging using an E-cadherin-GFP Mouse Reveals Disease- and Drug-Dependent Dynamic Regulation of Cell-Cell Junctions in Live Tissue.

Erami Z, Herrmann D, Warren SC, Nobis M, McGhee EJ, Lucas MC, Leung W, Reischmann N, Mrowinska A, Schwarz JP, Kadir S, Conway JRW, Vennin C, Karim SA, Campbell AD, Gallego-Ortega D, Magenau A, Murphy KJ, Ridgway RA, Law AM, Walters SN, Grey ST, Croucher DR, Zhang L, Herzog H, Hardeman EC, Gunning PW, Ormandy CJ, Evans TRJ, Strathdee D, Sansom OJ, Morton JP, Anderson KI, Timpson P.

Cell Rep. 2016 Jan 5;14(1):152-167. doi: 10.1016/j.celrep.2015.12.020. Epub 2015 Dec 24.

13.

Lyn modulates Claudin-2 expression and is a therapeutic target for breast cancer liver metastasis.

Tabariès S, Annis MG, Hsu BE, Tam CE, Savage P, Park M, Siegel PM.

Oncotarget. 2015 Apr 20;6(11):9476-87.

14.

Interaction of tetraspan(in) TM4SF5 with CD44 promotes self-renewal and circulating capacities of hepatocarcinoma cells.

Lee D, Na J, Ryu J, Kim HJ, Nam SH, Kang M, Jung JW, Lee MS, Song HE, Choi J, Lee GH, Kim TY, Chung JK, Park KH, Kim SH, Kim H, Seo H, Kim P, Youn H, Lee JW.

Hepatology. 2015 Jun;61(6):1978-97. doi: 10.1002/hep.27721. Epub 2015 Mar 18.

PMID:
25627085
15.

Modulation of tumor fatty acids, through overexpression or loss of thyroid hormone responsive protein spot 14 is associated with altered growth and metastasis.

Wellberg EA, Rudolph MC, Lewis AS, Padilla-Just N, Jedlicka P, Anderson SM.

Breast Cancer Res. 2014 Dec 4;16(6):481. doi: 10.1186/s13058-014-0481-z.

16.

Modeling of human uveal melanoma in zebrafish xenograft embryos.

van der Ent W, Burrello C, Teunisse AF, Ksander BR, van der Velden PA, Jager MJ, Jochemsen AG, Snaar-Jagalska BE.

Invest Ophthalmol Vis Sci. 2014 Sep 23;55(10):6612-22. doi: 10.1167/iovs.14-15202.

PMID:
25249605
17.

STAT3 mediates regorafenib-induced apoptosis in hepatocellular carcinoma.

Tai WT, Chu PY, Shiau CW, Chen YL, Li YS, Hung MH, Chen LJ, Chen PL, Su JC, Lin PY, Yu HC, Chen KF.

Clin Cancer Res. 2014 Nov 15;20(22):5768-76. doi: 10.1158/1078-0432.CCR-14-0725. Epub 2014 Sep 23.

18.

Gene signature-guided dasatinib therapy in metastatic breast cancer.

Pusztai L, Moulder S, Altan M, Kwiatkowski D, Valero V, Ueno NT, Esteva FJ, Avritscher R, Qi Y, Strauss L, Hortobagyi GN, Hatzis C, Symmans WF.

Clin Cancer Res. 2014 Oct 15;20(20):5265-71. doi: 10.1158/1078-0432.CCR-14-0800. Epub 2014 Aug 29. Erratum in: Clin Cancer Res. 2015 Jun 1;21(11):2653.

19.

Down-regulation of 5-HT1B and 5-HT1D receptors inhibits proliferation, clonogenicity and invasion of human pancreatic cancer cells.

Gurbuz N, Ashour AA, Alpay SN, Ozpolat B.

PLoS One. 2014 Aug 29;9(8):e105245. doi: 10.1371/journal.pone.0105245. eCollection 2014.

20.

V-ATPase inhibition regulates anoikis resistance and metastasis of cancer cells.

Schempp CM, von Schwarzenberg K, Schreiner L, Kubisch R, Müller R, Wagner E, Vollmar AM.

Mol Cancer Ther. 2014 Apr;13(4):926-37. doi: 10.1158/1535-7163.MCT-13-0484. Epub 2014 Jan 30.

Supplemental Content

Loading ...
Support Center